MENS (Jyong Biotech) Dividend Yield %: 0.00% (As of Jul. 02, 2026)


MENS Jyong Biotech Ltd MENS
10 GF Score
Price $2.22
! 3 Warning Signs
View Full Analysis

What is Jyong Biotech Dividend Yield %?

Jyong Biotech MENS +6.47% 10 Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 153 Biotechnology companies, Jyong Biotech ranks worse than 653594.12% on this metric.

As of today (2026-07-02), the Trailing Annual Dividend Yield of Jyong Biotech is 0.00%.

The historical rank and industry rank for Jyong Biotech's Dividend Yield % or its related term are showing as below:

MENS's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.48
* Ranked among companies with meaningful Dividend Yield % only.

Jyong Biotech's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-07-02), the Forward Dividend Yield % of Jyong Biotech is 0.00%.

Jyong Biotech's Dividends per Share for the six months ended in Dec. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Jyong Biotech  (NAS:MENS) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Jyong Biotech Dividend Yield % Related Terms


Jyong Biotech Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Jyong Biotech's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jyong Biotech Dividend Yield % Chart

Jyong Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
0.00 0.00 0.00 0.00 0.00

Jyong Biotech Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MENS vs ENLV, CNTB, ACOG: Dividend Yield % Comparison

For the Biotechnology subindustry, Jyong Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jyong Biotech Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jyong Biotech's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Jyong Biotech's Dividend Yield % falls into.


MENS
10GF Score
Jyong Biotech Ltd MENS
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jyong Biotech Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Jyong Biotech (MENS) has a Dividend Yield % of 0.00% as of Jul. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Jyong Biotech and its competitors. According to the industry distribution chart, Jyong Biotech ranks #999999 out of 153 companies in the Biotechnology industry.
Is Jyong Biotech's Dividend Yield % too high?
Jyong Biotech's current Dividend Yield % is 0.00%. Based on the distribution chart, Jyong Biotech ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Dividend Yield % compare to ENLV and CNTB?
According to the Biotechnology industry distribution chart, Jyong Biotech ranks #999999 out of 153 companies for Dividend Yield %. This places Jyong Biotech in the lower half of its industry. The industry median Dividend Yield % is 1.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.48, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Jyong Biotech and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jyong Biotech's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jyong Biotech Business Description

Address Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score

Get the complete analysis for MENS

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.22
Price